Desjardins Global Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $166K | Sell |
472
-270
| -36% | -$95.1K | 0.02% | 383 |
|
2023
Q3 | $278K | Sell |
742
-114
| -13% | -$42.8K | 0.03% | 327 |
|
2023
Q2 | $327K | Buy |
856
+26
| +3% | +$9.94K | 0.04% | 367 |
|
2023
Q1 | $287K | Buy |
830
+141
| +20% | +$48.8K | 0.04% | 358 |
|
2022
Q4 | $162K | Sell |
689
-1,255
| -65% | -$295K | 0.03% | 361 |
|
2022
Q3 | $477K | Hold |
1,944
| – | – | 0.06% | 233 |
|
2022
Q2 | $588K | Sell |
1,944
-1,466
| -43% | -$443K | 0.08% | 212 |
|
2022
Q1 | $1.4M | Sell |
3,410
-277
| -8% | -$114K | 0.12% | 161 |
|
2021
Q4 | $1.73M | Buy |
+3,687
| New | +$1.73M | 0.15% | 157 |
|